Clinical Trials Logo

Female Sexual Function clinical trials

View clinical trials related to Female Sexual Function.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06360692 Not yet recruiting - Body Image Clinical Trials

Impact of Nipple Micropigmentation in Mastectomized Women

Start date: June 1, 2024
Phase:
Study type: Observational

This will be a multicenter prospective descriptive case series study following a cohort. The micropigmentation/tattoo procedure will be carried out following the protocol established in each center (see annex x). The present investigation only involves measuring the impact that this technique has on the patients by collecting data in digital format before and after the CAP micropigmentation/tattoo that motivated their visit to the clinical service. CAP micropigmentation/tattooing is usually performed between 6 and 12 months after the breast reconstructive surgery has been completed, sufficient time for healing to complete and the breast to stabilize, although it can be performed from 2 months after the intervention. Nurses are responsible for performing micropigmentation/tattooing of the areola and nipple in mastectomized women.

NCT ID: NCT01420276 Not yet recruiting - Clinical trials for Female Sexual Function

Female Sexual Function and Back Pain

Start date: September 2011
Phase: Phase 4
Study type: Observational

Back paın is a common hormonal disorder in women that may affect the phases of female sexual function (FSD). We investigated sexual function in patients with back paın A total of 54 women with back paın and 27 age matched voluntary healthy women who served as the as control group were evaluated with a detailed medical and sexual history, including a female sexual function index (FSFI) questionnaire and the Beck Depression Inventory. Serum prolactin, dehydroepiandrosterone sulfate, free testosterone, androstenedione, 17alpha-hydroxyprogesterone, estradiol, free thyroxin and thyrotropin were measured. These variables were compared statistically between the 2 groups.